Get Moving On Social Media, But Carefully, Attorneys And Marketers Say
Executive Summary
While many medical device and drug companies fear delving into social media without clear guidance from FDA, speakers at the Food & Drug Law Institute's 2010 annual conference advised companies to move ahead on their own, but with caution
You may also be interested in...
FDA's Advertising Letters Continue To Grow, Both In Volume And Depth
FDA's Division of Drug Marketing, Advertising and Communication appears to be shifting the way it writes citations to firms, increasing not just the number of letters it sends, but the number of problems it lists within each letter
FDA's Advertising Letters Continue To Grow, Both In Volume And Depth
FDA's Division of Drug Marketing, Advertising and Communication appears to be shifting the way it writes citations to firms, increasing not just the number of letters it sends, but the number of problems it lists within each letter
Who's Liable For Online Content? Pharma, Marketers Disagree (Slightly)
Compensation and collaboration - as well as creation - should be the triggers for determining a pharmaceutical company's liability for Internet content, Rohit Bhargava of Ogilvy 360 Digital Influence advised FDA during a Nov. 12-13 hearing on promoting medical products on the Internet and in social media